Abiopharma

Director PROEHL GERALD T 🟢 acquired 198.3K shares (9 derivative) of TENAX THERAPEUTICS, INC. (TENX) at $9,968.00 ($1.6M) Transaction Date: Jan 09, 2026 | Filing ID: 000001

Director Congleton Jon 🔴 sold 16.2K shares of Mineralys Therapeutics, Inc. (MLYS) at $33.15 Transaction Date: Jan 12, 2026 | Filing ID: 000002

Levy Adam Scott 🔴 sold 10.8K shares of Mineralys Therapeutics, Inc. (MLYS) at $32.14 Transaction Date: Jan 12, 2026 | Filing ID: 000002

Rodman David Malcom 🟡 adjusted position in 8.5K shares (2 derivative) of Mineralys Therapeutics, Inc. (MLYS) at $33.27 Transaction Date: Jan 09, 2026 | Filing ID: 000004

Director Almenoff June Sherie 🟢 acquired 150.0K shares (5 derivative) of TENAX THERAPEUTICS, INC. (TENX) at $3,200.00 ($1.5M) Transaction Date: Jan 09, 2026 | Filing ID: 000001

Mastrocola Lauren 🔴 sold 344 shares of Praxis Precision Medicines, Inc. (PRAX) at $275.74 Transaction Date: Jan 12, 2026 | Filing ID: 000005

Sniecinski Megan 🔴 sold 885 shares of Praxis Precision Medicines, Inc. (PRAX) at $275.74 Transaction Date: Jan 12, 2026 | Filing ID: 000006

Nemiroff Alex 🔴 sold 768 shares of Praxis Precision Medicines, Inc. (PRAX) at $275.74 Transaction Date: Jan 12, 2026 | Filing ID: 000005

Kelly Timothy Edwin 🔴 sold 943 shares of Praxis Precision Medicines, Inc. (PRAX) at $275.74 Transaction Date: Jan 12, 2026 | Filing ID: 000005

New Form 3 - INVO Fertility, Inc. Filed: 2026-01-13 AccNo: 0001493152-26-002101 Size: 11 KB

Director Doogan Declan 🟢 acquired 150.0K shares (5 derivative) of TENAX THERAPEUTICS, INC. (TENX) at $3,200.00 ($1.5M) Transaction Date: Jan 09, 2026 | Filing ID: 000001

Director Hunter Robyn 🟢 acquired 150.0K shares (4 derivative) of TENAX THERAPEUTICS, INC. (TENX) at $992.00 ($1.5M) Transaction Date: Jan 09, 2026 | Filing ID: 000001

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Lexaria Bioscience Corp. - Warrant.

NASDAQ traded attribute type Security_Name was changed. Previous value: Co-Diagnostics, Inc. - Common Stock. New value: Co-Diagnostics, Inc. - Common Stock.

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Lexaria Bioscience Corp. - Warrant.